Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Mountain Crest Acquisition II (BTTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Siemens Healthineers AG (SEMHFResearch Report) and Mountain Crest Acquisition II (BTTXResearch Report).

Siemens Healthineers AG (SEMHF)

In a report released yesterday, Hassan Al-Wakeel from Barclays maintained a Hold rating on Siemens Healthineers AG, with a price target of EUR60.00. The company’s shares closed last Wednesday at $61.20.

According to, Al-Wakeel is ranked #6344 out of 7928 analysts.

Currently, the analyst consensus on Siemens Healthineers AG is a Moderate Buy with an average price target of $76.16.

See Insiders’ Hot Stocks on TipRanks >>

Mountain Crest Acquisition II (BTTX)

In a report released yesterday, Keay Nakae from Chardan Capital reiterated a Buy rating on Mountain Crest Acquisition II, with a price target of $18.00. The company’s shares closed last Tuesday at $2.10, close to its 52-week low of $2.01.

According to, Nakae is a 4-star analyst with an average return of 12.1% and a 43.5% success rate. Nakae covers the Healthcare sector, focusing on stocks such as Sonnet BioTherapeutics Holdings, Arrowhead Pharmaceuticals, and Emergent Biosolutions.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mountain Crest Acquisition II with a $16.50 average price target, implying a 716.0% upside from current levels. In a report issued on March 15, LifeSci Capital also maintained a Buy rating on the stock with a $15.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SEMHF:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed